Test Price
2,800 AED✅ Home Collection Available
GNA11 Gene Hypocalcemia, Autosomal Dominant 2 (Genetic Test) in UAE | 2,800 AED
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity via ISO 15189 Certified Genomics Lab. Premium Hospital‑Grade Home Collection with Cold‑Chain Logistics, VIP Mobile Phlebotomy, Telephonic Post‑Test Clinical Guidance, and Direct Insurance Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing (NGS) test screens the entire GNA11 gene for pathogenic variants linked to autosomal dominant hypocalcemia type 2 (ADH2), a rare disorder of calcium metabolism. The test enables precise diagnosis and personalized management of calcium homeostasis.
| Feature | Our NGS Test (GNA11 Full Gene) | Sanger Sequencing (Alternative) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina® platform, 99.9% coverage) | Capillary electrophoresis, single‑exon analysis |
| Diagnostic Sensitivity | 99.9% (all exons ± 10 bp intronic flanks) | ~95% (may miss deep intronic or regulatory variants) |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks |
| ISO Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Often uncertified locally |
| Price | 2,800 AED | 3,200 – 4,500 AED |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I emphasize that every genetic result must be correlated with the patient’s personal and family history. A pathogenic GNA11 variant confirms autosomal dominant hypocalcemia type 2, but a negative report does not exclude other genetic or acquired causes. I strongly recommend a consultation with your endocrinologist or clinical geneticist to interpret this test within the full clinical picture.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403)
Advisory: Do Not Discontinue Medications Without Medical Consultation
Medication Warning: Do not discontinue any prescribed medication, including calcium supplements or active vitamin D analogues, without consulting your treating physician.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or active infection – postpone testing until recovery.
- Recent blood transfusion (<4 weeks) – may interfere with germline DNA purity.
- Inability to provide informed consent (mandatory as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability).
🚨 Seek immediate emergency care if you experience: severe muscle cramps, tetany, laryngospasm, seizures, or cardiac arrhythmias (prolonged QTc). These may indicate life‑threatening hypocalcemia.
Patient FAQ & Clinical Guidance
1. What is the GNA11 genetic test used for?
The GNA11 NGS test detects gene mutations causing autosomal dominant hypocalcemia type 2, enabling precise diagnosis. This advanced DNA analysis identifies pathogenic variants in the GNA11 gene responsible for a rare form of inherited hypocalcemia. By confirming the molecular cause, clinicians can tailor calcium and vitamin D therapy, screen at‑risk relatives, and avoid unnecessary treatments. The test is performed on a single blood sample, extracted DNA, or an FTA card, with results available in 3–4 weeks.
2. How is the sample collected?
Sample collection is performed via VIP mobile phlebotomy at your home or office. A sterile, temperature‑controlled courier ensures specimen integrity. Acceptable samples include whole blood (EDTA tube), extracted DNA, or dried blood spot on FTA card. The process takes about 5 minutes and is available daily from 8 AM to 11 PM.
3. Does the test price include genetic counselling?
Yes. The 2,800 AED fee covers pre‑test genetic counselling, DNA extraction, NGS, interpretation, and post‑test clinical guidance. A mandatory pre‑test counselling session (in‑clinic or telehealth) includes a multi‑generation pedigree, inheritance risk explanation, and consent. After results are released, a 30‑minute telephonic consultation with a clinical geneticist or endocrinologist is included.
4. Is the test accurate and does insurance cover it?
Our ISO 15189‑accredited lab uses Illumina platforms with 99.9% coverage accuracy. Results are reviewed by a team of consultant geneticists. We contract with major insurance networks like Daman, AXA, Neuron, and others. Send your insurance card via WhatsApp for immediate coverage verification.
5. How are results reported and what do I do after?
The final report includes variant nomenclature (HGVS), classification per ACMG guidelines, and clinical correlation. Positive results trigger immediate communication with your referring physician. For variants of uncertain significance, our lab offers periodic re‑analysis at no extra cost. All data is stored in compliance with UAE PDPL, and you have the right to request deletion after 10 years.
UAE Regulatory & Data Privacy Adherence
This test complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility holds ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and applies CLSI/IQCP quality standards.
Clinical & Logistical Metadata
| Test Name | GNA11 Gene Hypocalcemia, Autosomal Dominant 2 (Full Gene Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (Illumina®, full gene coverage, 99.9% sensitivity) |
| ICD-10-CM Code | E83.51 |
| LOINC Code | 91711-5 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians